Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study.
Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study.
复制标题
DOI:
10.7150/ijbs.50654
复制
发表时间:
2021
影响因子:
9.2
通讯作者:
Lv S
中科院分区:
文献类型:
--
作者:
Lv Z;Lv S
Objective: Since December 2019, an outbreak of coronavirus disease 2019 (COVID 19) has been experienced from Wuhan, China to the world. A retrospective cohort study was conducted to summarize the clinical characteristics of patients with COVID-19 and to explore the risk factors affecting the disease duration in Jiangan Fangcang shelter hospital, Wuhan, China. Methods: Clinical characteristics of 409 patients with COVID-19 were retrospectively analyzed. We describe the clinical characteristics and distribution of discharge time or transfer time for each patient. Then we performed univariate and multivariate Cox regression analysis to identify potential risk factors for progression from non-severe to severe COVID-19 or death. Results: The median disease duration of all patients was 23 days (IQR 19-28). The main symptoms of the patient were fever (95.6%), cough (74.3%), tiredness (21.5%), and so on. Comorbidities mainly included hypertension (30.6%) diabetes (17.6%) and heart disease (12.5%). The univariate Cox regression analysis showed that old age, number of symptoms, the combination of hypertension, heart disease and pulmonary disease were associated with the progression of disease. The multivariate Cox regression analysis showed that old age (HR: 7.294; 95% CI: 1.442-36.888; P = 0.016), the combination of hypertension (HR: 2.230; 95% CI: 1.090-4.562; P = 0.028) and heart disease (HR: 2.650; 95% CI: 1.079-6.510; P = 0.034) were independent risk factors for progression of COVID-19. Conclusions: The age of the patient, the combination of hypertension and heart disease were independent risk factors for the progression of COVID-19. Cautions should be raised for patients with these risk factors.
登录
查看更多内容
影响因子:
64.5
作者:
Dimitrov DS
通讯作者:
Dimitrov DS
影响因子:
5.2
作者:
He, Feng;Luo, Qingqing;Cao, Jie
通讯作者:
Cao, Jie
影响因子:
28.2
作者:
Liu, Yuwei;Du, Xuebei;Zhao, Yan
通讯作者:
Zhao, Yan
影响因子:
82.9
作者:
Kuba K;Imai Y;Rao S;Gao H;Guo F;Guan B;Huan Y;Yang P;Zhang Y;Deng W;Bao L;Zhang B;Liu G;Wang Z;Chappell M;Liu Y;Zheng D;Leibbrandt A;Wada T;Slutsky AS;Liu D;Qin C;Jiang C;Penninger JM
通讯作者:
Penninger JM
DOI:
10.26355/eurrev_202003_20711
发表时间:
2020-03-01
影响因子:
3.3
作者:
Zheng, F.;Tang, W.;Zhou, Z-G
通讯作者:
Zhou, Z-G